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Abstract. 
 
Acetylcholinesterase (AChE) occurs in both 
asymmetric forms, covalently associated with a collage-
nous subunit called Q (ColQ), and globular forms that 
may be either soluble or membrane associated. At the 
skeletal neuromuscular junction, asymmetric AChE
is anchored to the basal lamina of the synaptic cleft, 
where it hydrolyzes acetylcholine to terminate synaptic 
transmission. AChE has also been hypothesized to play 
developmental roles in the nervous system, and ColQ is 
also expressed in some AChE-poor tissues. To seek 
roles of ColQ and AChE at synapses and elsewhere, we 
 
generated ColQ-deficient mutant mice. 
 
ColQ
 
2
 
/
 
2
 
 mice 
completely lacked asymmetric AChE in skeletal and 
cardiac muscles and brain; they also lacked asymmetric 
forms of the AChE homologue, butyrylcholinesterase. 
Thus, products of the 
 
ColQ
 
 gene are required for as-
sembly of all detectable asymmetric AChE and butyryl-
cholinesterase. Surprisingly, globular AChE tetramers 
were also absent from neonatal 
 
ColQ
 
2
 
/
 
2
 
 muscles, sug-
gesting a role for the 
 
ColQ
 
 gene in assembly or stabili-
zation of AChE forms that do not themselves contain
a collagenous subunit. Histochemical, immunohis-
tochemical, toxicological, and electrophysiological as-
says all indicated absence of AChE at 
 
ColQ
 
2
 
/
 
2
 
 neu-
romuscular junctions. Nonetheless, neuromuscular 
function was initially robust, demonstrating that AChE 
and ColQ do not play obligatory roles in early phases of 
synaptogenesis. Moreover, because acute inhibition of 
synaptic AChE is fatal to normal animals, there must 
be compensatory mechanisms in the mutant that allow 
the synapse to function in the chronic absence of 
AChE. One structural mechanism appears to be a par-
tial ensheathment of nerve terminals by Schwann cells. 
Compensation was incomplete, however, as animals 
lacking ColQ and synaptic AChE failed to thrive and 
most died before they reached maturity.
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A
 
CETYLCHOLINESTERASE
 
 (AChE)
 
1
 
 is concentrated in
the synaptic cleft of the skeletal neuromuscular
junction. Acetylcholine released from motor nerve
terminals is rapidly inactivated by the synaptic AChE,
thereby limiting the action of the neurotransmitter. The
importance of the enzyme is demonstrated by the effects
of blocking its activity. Inhibition of AChE, for example
by nerve gas, causes prolonged activation of acetylcholine
receptors (AChRs), leading to desensitization of the re-
ceptors, respiratory paralysis, and death. Partial inhibition
of AChE, for example by overexposure to insecticides, re-
sults in excessive influx of calcium through the AChR’s
ion channel, which leads to local necrotic myopathy (Leon-
ard and Salpeter, 1979; Wecker et al., 1986). On the other
hand, inhibitors of AChE are therapeutically useful to pa-
tients with diseases of inadequate neurotransmission in
which levels of AChRs are decreased (such as acquired
autoimmune myasthenia gravis; Engel, 1994a) or insuffi-
cient acetylcholine is released (such as familial infantile
myasthenia; Engel, 1994b).
Although the function of AChE is apparently simple, its
patterns of structure and distribution are remarkably com-
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1. 
 
Abbreviations used in this paper:
 
 AChE, acetylcholinesterase; AChR,
acetylcholine receptor; BuChE, butyrylcholinesterase; ColQ, collagen Q;
DS, detergent-soluble; ES cells, embryonic stem cells; HS, high-salt; LS,
low-salt; mepps, miniature endplate potentials; PRAD, proline-rich at-
tachment domain; VVA-B4, 
 
Vicia villosa
 
 agglutinin-B4. 
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plex. First, the transcript of the AChE gene is subject to al-
ternative splicing and its protein products can associate co-
valently with each other and with noncatalytic subunits
(for review see Massoulié et al., 1993, 1998). Second, the
oligomers can occur in cytoplasmic, membrane-bound
and extracellular matrix–associated forms (for review see
Massoulié and Bon, 1982; Toutant and Massoulié, 1988).
Third, AChE is found not only at neuromuscular junc-
tions, but also at cholinergic interneuronal synapses, in
some noncholinergic neurons, and in some nonneural cells
such as erythrocytes (Massoulié et al., 1993). Fourth, a re-
lated enzyme, butyrylcholinesterase (BuChE), capable of
hydrolyzing acetylcholine, is expressed in some of the
same sites as AChE, including the neuromuscular junction
(for review see Chatonnet and Lockridge, 1989). Based in
part on their complex patterns of expression in embryos
and adults, AChE and BuChE have been hypothesized to
play a variety of noncholinergic and even noncatalytic
roles in embryos and adults (for review see Layer and
Willbold, 1995).
Much of the AChE at the neuromuscular junction oc-
curs in forms that have been called asymmetric. Asymmet-
ric forms of AChE were initially identified in 
 
Torpedo
 
 and
 
Electrophorus
 
 electric organ; they were defined and distin-
guished from the remaining (globular) forms by virtue of
their anomalous sedimentation properties in sucrose den-
sity gradients. The asymmetry was shown to reflect the as-
sociation of catalytic AChE subunits with a tail that was
rod-shaped, collagenase-sensitive, and rich in amino acids
characteristic of collagens (hydroxyproline and hydroxy-
lysine; Lwebuga-Mukasa et al., 1976; Rosenberry and
Richardson, 1977). Three asymmetric forms of AChE were
characterized, in which one, two, or three tetramers of cat-
alytic subunits (now called AChE
 
T
 
) were disulfide-bonded
to a single collagenous triple helical tail. These forms are
called A
 
4
 
, A
 
8
 
, and A
 
12
 
, to indicate the total number of cat-
alytic subunits per oligomer (Massoulié and Bon, 1982).
Hall (1973) showed that asymmetric forms of AChE
were selectively associated with synapse-containing re-
gions of rodent skeletal muscle, whereas globular forms
were more uniformly distributed. Later, it was found that
synaptic AChE was stably associated with the basal lam-
ina that runs between the motor nerve terminal and the
postsynaptic membrane at the neuromuscular junction (Mc-
Mahan et al., 1978; Sanes and Hall, 1979). The collagen tail
of asymmetric AChE is likely to be critical for anchoring
the enzyme to the basal lamina, perhaps by association
with proteoglycans (Bon et al., 1978; Vigny et al., 1983;
Brandan et al., 1985; Deprez and Inestrosa, 1995; Rossi
and Rotundo, 1996; Rotundo et al., 1997). However, the
relationship of asymmetric AChE to the synapse is not
completely understood in that some synaptic AChE may
be globular (Anglister et al., 1994) and some asymmetric
AChE is found extrasynaptically (Carson et al., 1979; Youn-
kin et al., 1982; Sketelj and Brzin, 1985).
Structural and functional analyses of the asymmetric
and synaptic forms of AChE were delayed by the difficulty
of isolating its collagenous subunit. Recently, however,
cDNAs encoding an AChE-associated collagenous sub-
unit called Q (ColQ) were molecularly cloned from rat
muscle (Krejci et al., 1997), based on homology to a pre-
viously isolated Q subunit from 
 
Torpedo
 
 (Krejci et al.,
1991). Antibodies to recombinant ColQ recognize native
asymmetric AChE and BuChE, and coexpression of
cDNAs encoding ColQ and AChE
 
T
 
 generates asymmetric
AChE in heterologous cells (Krejci et al., 1997). Assembly
of asymmetric AChE involves interaction of a proline-rich
attachment domain (PRAD) in ColQ with a tryptophan
amphiphilic tetramerization domain in AChE
 
T
 
 (Bon et al.,
1997; Krejci et al., 1997; Simon et al., 1998). Alternatively
spliced products of the 
 
ColQ
 
 gene that encode a PRAD
but no collagenous domain have been described; they may
organize other AChE isoforms or interact with other pro-
teins. In fact, 
 
ColQ
 
 RNA is expressed in many tissues with
little or no asymmetric AChE, suggesting that it may have
additional roles (Krejci et al., 1997).
Here, we have used homologous recombination in em-
bryonic stem (ES) cells to inactivate the 
 
ColQ
 
 gene in
mice, thereby allowing us to assess roles of the ColQ pro-
tein in vivo. Using a combination of biochemical, histolog-
ical, and electrophysiological methods, we answered the
following questions. Does asymmetric AChE in muscle
require ColQ protein for assembly or accumulation? Are
only asymmetric forms of AChE ColQ-dependent? How
much of the AChE concentrated at the neuromuscular
junction is ColQ-dependent? Does asymmetric BuChE re-
quire the ColQ gene product? How does loss of ColQ af-
fect the structure and function of the neuromuscular junc-
tion? Is AChE or ColQ required for proper neuromuscular
development? Is ColQ required for the structure or func-
tion of nonmuscle tissues?
 
Materials and Methods
 
Generation of Mutant Mice
 
Genomic clones containing the 
 
ColQ
 
 gene were isolated by screening a
129sv strain mouse genomic library (Stratagene) with cDNAs encoding
rat ColQ (Krejci et al., 1997). For targeting vector PRAD1 (Fig. 1 a), a
0.8-kb EcoRI-HindIII fragment containing the exon encoding the PRAD
domain as well as adjacent intronic sequences was replaced by a PGK-
 
neo
 
cassette (Tybulewicz et al., 1991). For targeting vector PRAD2 (Fig. 1 a),
a 0.6-kb HindIII fragment containing the PRAD exon was replaced by a
cassette containing 
 
neo
 
 plus the 
 
Escherichia coli
 
 
 
lacZ
 
 gene, for monitoring
gene expression. The PRAD2 vector also contained a diphtheria toxin-A
gene for negative selection (Yagi et al., 1990). Both constructs were trans-
fected into R1 ES cells (Nagy et al., 1993) by electroporation. Homolo-
gous recombinants were identified by PCR and confirmed by probing ge-
nomic Southern blots with an 0.8-kb fragment of the 
 
ColQ
 
 gene that was
entirely external to the targeting vector (Fig. 1 a). Chimeric mice from one
PRAD1 and two PRAD2 ES cell clones gave rise to heterozygous and
then homozygous mutant mice. The PRAD2 vector contained a 
 
lacZ
 
gene, but no 
 
b
 
-galactosidase activity was detected in heterozygotes, either
histochemically or immunohistochemically.
 
Histology
 
For immunohistochemistry, sternomastoid and tibialis anterior muscles
were embedded in Tissue-Tek OCT compound (Sakura Finetek USA),
frozen in liquid nitrogen–cooled isopentane, and sectioned at 10 
 
m
 
m in a
cryostat. Sections were blocked for 1 h with 2% BSA and 5% normal goat
serum in PBS, incubated with primary antibodies for 1–2 h, washed, and
then reincubated with secondary antibodies for another 1–2 h. Antibodies
to the following antigens were used: ColQ (Krejci et al., 1997), AChE (a
gift of Terrone Rosenberry, Mayo Clinic), 
 
a
 
-sarcoglycan, 
 
b
 
-dystroglycan,
utrophin (Novocastra Laboratories Ltd.), rapsyn (Phillips et al., 1991),
and agrin (a gift of Z. Hall, University of California, San Francisco).
FITC-conjugated 
 
Vicia villosa
 
 agglutinin-B4 (VVA-B4) was obtained
from Sigma Chemical Co. and rhodamine-
 
a
 
-bungarotoxin was obtained
from Molecular Probes. 
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Cholinesterase activity was detected by the histochemical method of
Karnovsky and Roots (1964) on sections fixed with 2% paraformaldehyde
in PBS. To distinguish AChE from BuChE, the reaction mixture was sup-
plemented with 10
 
2
 
4
 
 M tetraisopropylpyrophosphoramide (iso-OMPA), a
selective inhibitor of BuChE, or with 5 
 
3
 
 10
 
2
 
5
 
 M 1:5-bis (4-allyldimeth-
ylammoniumphenyl)-pentan-3-one dibromide (BW284c51), a selective in-
hibitor of AChE (Austin and Berry, 1953). Where indicated, sections
were treated with 1% Triton X-100 for 60 min at room temperature or
highly purified bacterial collagenase (800 U/ml, type VII; Sigma Chemical
Co.) for 60 min at 37
 
8
 
C before fixation and staining.
For electron microscopy, mice were perfused with lactated Ringer’s so-
lution followed by 4% paraformaldehyde and 4% glutaraldehyde in 100 mM
cacodylate buffer, pH 7.2. Sternomastoid muscles were dissected and fixed
overnight at 4
 
8
 
C. The endplate-rich region of the muscle was refixed in
1% OsO
 
4
 
 in cacodylate buffer, dehydrated, and embedded in Araldite.
Thin sections were stained with uranyl acetate and lead citrate.
 
Biochemistry
 
Mice were killed and tissues were homogenized in a glass Potter homoge-
nizer in 1 ml of low-salt (LS) buffer, which contained 50 mM Tris, pH 7.0,
40 mM MgCl
 
2
 
, 1% Triton X-100, 2 mM benzamidine, 40 
 
m
 
g/ml leupeptin,
and 25 
 
m
 
g/ml pepstatin. The homogenates were centrifuged for 20 min at
60,000 rpm, the supernatant was removed, and the pellet was homoge-
nized in a second aliquot of LS buffer and centrifuged again. The two re-
sulting supernatants comprised the detergent-soluble (DS) extracts. The
pellet was then homogenized with 300 
 
m
 
l of high-salt (HS) buffer, which
consisted of LS buffer plus 0.8 M NaCl. After centrifugation, the superna-
tant (HS extract) and the pellet were both saved.
Samples of the DS and HS extracts were analyzed by sedimentation in
5–20% sucrose gradients containing 50 mM Tris, pH 7.0, 40 mM MgCl
 
2
 
,
1% Brij96, and 0.4 M NaCl. Centrifugation was in an SW41 rotor for 16 h
at 39,000 rpm. About 75 fractions of 150 
 
m
 
l were collected from the bot-
tom of the tube. 60-
 
m
 
l aliquots were transferred to a microtiter plate. Cho-
linesterase activity was assayed colorimetrically, using acetylcholine as
substrate (Ellman et al., 1961). To assay AChE, iso-OMPA (10
 
2
 
4
 
 M) was
included to inhibit BuChE. To assay BuChE, BW284c51 (10
 
2
 
6
 
 M) was in-
cluded to inhibit AChE. Alkaline phosphatase (6.1 S) and 
 
b
 
-galactosidase
(16 S) from 
 
E
 
.
 
 coli
 
 were included as internal sedimentation standards, and
their activity profiles were used to establish a linear relationship between
the fraction numbers and Svedberg units (Simon et al., 1998). All reagents
were from Sigma Chemical Co.
 
Electrophysiology
 
ColQ
 
2
 
/
 
2
 
 mice or control littermates were killed and immediately exsan-
guinated. Hemi-diaphragms with their associated phrenic nerves were iso-
lated. The two hemi-diaphragms were separated and each was mounted in
Figure 1. Generation of a
ColQ mutant. (a) The tar-
geted alleles. The top line
shows schematic of the ColQ
protein, including the amino-
terminal PRAD domain that
links ColQ to the catalytic
subunit of AChE. The sec-
ond line shows gene struc-
ture, with exons indicated by
dark boxes and introns by
lines. The third and fourth
lines show the PRAD1 and
PRAD2 vectors, in which the
exon encoding the PRAD
domain was deleted. The
fifth and sixth lines, labeled
recombinant, show pre-
dicted structures of the mu-
tant alleles. Location of
probe used for Southern
blots is indicated. (b) South-
ern blots of wild-type ES
cells and homologous recom-
binant PRAD1 and PRAD2
clones. In the recombinants,
the 3.2-kb EcoRI fragment
from the wild-type gene is
shifted to 4.6 kb. (c) PCR as-
say used to genotype ColQ
mutants. (d) Weight of
ColQ2/2 mice (bottom line)
and littermates (top line).
Mutant homozygotes are
smaller than littermates by
P5, and weigh less than half
as much as littermates by
P20. Bars show mean 6
SEM. n 5 4–14. 
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a 2-ml bath lined with Rhodorsil (Rhône-Poulenc) and superfused with
saline of the following composition: 154 mM NaCl, 5 mM KCl, 2 mM
CaC1
 
2
 
, 1 mM MgCl
 
2
 
, 5 mM Hepes, pH 7.4, and 11 mM glucose. The solu-
tion was bubbled with pure O
 
2
 
.
The membrane potential and miniature endplate potentials (mepps)
were recorded from endplate regions at room temperature (22–24
 
8
 
C) with
intracellular microelectrodes filled with 3 M KCl (resistance of 16–26
M
 
V
 
), using conventional techniques and an Axoclamp-2A system (Axon
Instruments). Recordings were made continuously from the same end-
plate before and throughout application of the cholinesterase inhibitors
tested. Data were digitized and analyzed using a computer equipped with
an analogue and digital I/O interface board (DT2821; Data Translation)
and a program kindly provided by Dr. John Dempster (University of
Strathclyde, Scotland). Mepps were analyzed individually for amplitude
and time course.
 
Results
 
Generation of a ColQ Mutant
 
Clones encoding the 
 
ColQ
 
 gene were isolated from a ge-
nomic library and used to produce two targeting vectors,
PRAD1 and PRAD2 (Fig. 1 a). Both vectors deleted the
PRAD domain of ColQ, which forms the binding site for
the catalytic (AChE
 
T
 
) subunits of AChE (Bon et al., 1997).
Both targeting vectors gave rise to homologous recombi-
nant ES cells, germline chimeras, heterozygotes, and ho-
mozygotes (Fig. 1, b and c). Phenotypes of PRAD1 and
PRAD2 homozygotes were identical, so both are called
 
ColQ
 
2
 
/
 
2
 
 and described together here.
Homozygous 
 
ColQ
 
2
 
/
 
2
 
 mice were born in expected num-
bers, and were externally indistinguishable from heterozy-
gous (
 
ColQ
 
1
 
/
 
2
 
) and wild-type siblings at birth. Around 5 d
after birth (postnatal day [P]5), however, 
 
ColQ
 
2
 
/
 
2
 
 mice be-
gan to exhibit a tremor when moving. The tremor persisted
throughout life. The homozygotes remained active, respon-
sive, and capable of feeding, but failed to thrive, and grew
at a slower rate than littermates (Fig. 1 d). About half of
the 
 
ColQ
 
2
 
/
 
2
 
 mice died at about the time of weaning (P21)
and around two-thirds of the survivors died over the next
few weeks. 10–20% of 
 
ColQ
 
2
 
/
 
2
 
 mice lived into adulthood
(
 
.
 
3 mo) but remained much smaller than littermates.
 
ColQ Mutants Lack Synaptic AChE
 
Sections of skeletal muscle from 
 
ColQ
 
2
 
/
 
2
 
 mutants and lit-
termates were doubly stained with an antiserum to recom-
binant ColQ plus rhodamine-
 
a
 
-bungarotoxin, which binds
to AChRs and thereby marks synaptic sites. In controls,
ColQ was concentrated at synaptic sites and was undetect-
able extrasynaptically (Fig. 2, a and a
 
9
 
). In 
 
ColQ
 
2
 
/
 
2
 
 mu-
tants, AChR-rich synaptic sites were nearly normal in size,
shape, and distribution (see below) but, as expected, bore
no ColQ (Fig. 2, b and b
 
9
 
).
The ColQ subunit is believed to anchor AChE to the
basal lamina at the neuromuscular junction. To obtain de-
finitive evidence on this point, we stained sections of mu-
tant and control muscle with antibodies specific for the
AChE catalytic subunit. This antibody recognizes both of
the known alternatively spliced products (T and H) of the
mammalian AChE gene (Duval et al., 1992). AChE was
abundant at all synaptic sites in controls, but undetectable
in homozygotes (Fig. 2, c and d).
This result suggested that ColQ is required for accumu-
lation of all synaptic AChE. An alternative explanation,
 
however, was that the association of AChE with synaptic
membranes or matrix had merely been weakened in the
absence of its collagenous tail, in which case AChE might
have been present at synapses in vivo but lost during prep-
aration of sections. Therefore, we performed two ad-
ditional tests to seek AChE at synaptic sites in 
 
ColQ
 
2
 
/
 
2
 
muscle in situ. First, we injected fasciculin-2, a selective in-
hibitor of AChE (Rodriguez-Ithurralde et al., 1983) into
 
ColQ
 
2
 
/
 
2
 
 mice and their littermates. This inhibitor was
chosen because it penetrates the central nervous system
poorly, and is therefore believed to exert its effects pre-
dominantly on peripheral AChE. Fasciculin-2 (3–6 
 
m
 
g/g,
injected intraperitoneally) caused tremor followed by flac-
cid paralysis in controls. In mutants, in contrast, effects of
fasciculin were minor, and injected animals were reflexive
and capable of righting. Second, we recorded mepps from
muscle fibers of 
 
ColQ
 
2
 
/
 
2
 
 mice and littermate controls
(Fig. 3). The decay times of mepps were variable but
on average slower in homozygotes than in controls (data
not shown), presumably because AChE terminates neu-
rotransmitter action at normal neuromuscular junctions
(Whathey et al., 1979), whereas diffusion does so in 
 
ColQ
 
2
 
/
 
2
 
muscle. More importantly, addition of fasciculin greatly
slowed the decay of mepps in normal muscle, but had no
significant effect on the time course of mepps in 
 
ColQ
 
2
 
/
 
2
 
muscle (from 3.57 
 
6
 
 0.18 to 3.47 
 
6
 
 0.07 ms in four experi-
ments;
 
 P 
 
.
 
 0.2). Together, these toxicological and physio-
logical tests support the idea that 
 
ColQ
 
2
 
/
 
2
 
 mutants lack
functional synaptic AChE.
 
ColQ Is Required for Assembly of All Asymmetric and 
Some Globular AChE in Muscle
 
We used sucrose density gradient centrifugation to assess
Figure 2. ColQ2/2 endplates lack AChE. Sections of skeletal
muscle from ColQ1/2 and ColQ2/2 littermates were double-labeled
with rhodamine-a-bungarotoxin plus antibodies to either the cat-
alytic (AChET) or collagenous (ColQ) subunit of AChE. Ho-
mozygous mutant endplates lacked not only ColQ but also all de-
tectable AChET. Bar, 10 mm.Feng et al. Collagen Q Mutant Lacks Synaptic Acetylcholinesterase 1353
the molecular forms of AChE present in ColQ2/2 muscles.
Globular forms are extracted into detergent-containing
buffers at low ionic strength, whereas asymmetric (colla-
gen-tailed forms) are extracted only at high ionic strength
(Bon et al., 1978). Therefore, we first homogenized mus-
cles with detergent-containing LS buffers, then reincu-
bated the pellet with HS buffers to selectively solubilize
asymmetric forms.
Control (ColQ1/1 and ColQ1/2) muscles contain three
asymmetric forms, corresponding to a single helical trimer
of ColQ chains attached to one, two, or three tetramers of
catalytic subunits (A4, A8, and A12, respectively; Massoulié
and Bon, 1982). In contrast, no asymmetric forms were de-
tectable in ColQ2/2 muscle (Fig. 4, b and c). Because some
asymmetric AChE is difficult to solubilize from tissue
(Rossi and Rotundo, 1993), we also assayed the pellet re-
maining after HS and detergent extraction. AChE activity
in insoluble fractions was 14% of that in the HS extract for
ColQ1/1 muscles (n 5 4), and 30% of that in the HS ex-
tract for ColQ1/2 muscles. However, AChE activity was
undetectable in the insoluble fraction from ColQ2/2 mus-
cles. Similar results were obtained with muscles from neo-
nates (P0) and at P20. Thus, all asymmetric AChE in mus-
cle requires ColQ for its assembly and/or accumulation.
Surprisingly, loss of AChE in ColQ2/2 mice was not
limited to the asymmetric forms. At birth, three major
peaks of AChE activity were distinguishable in detergent
extracts of control muscle, corresponding to amphiphilic
monomers and dimers (G1
a and G2
a) and nonamphiphilic
tetramers (G4
na; Massoulié et al., 1998). G1
a and G2
a were
retained in neonatal ColQ2/2 muscles, but the G4
na peak
was almost entirely absent (Fig. 4 a). In addition, the pool
of globular tetramers extracted by HS was absent from
ColQ2/2 neonates (Fig. 4 b). At P20, however, amphiphilic
and nonamphiphilic tetramers (G4
a and G4
na) as well as
G1
a and G2
a forms were present in ColQ2/2 muscles (data
not shown). Thus, ColQ-independent mechanisms for as-
sembly or retention of G4 do exist (see Discussion).
ColQ Is Required for Assembly of Asymmetric BuChE
BuChE is homologous to AChE, hydrolyzes acetylcholine,
and is present at the neuromuscular junction (Chatonnet
and Lockridge, 1989; Chapron et al., 1997). Like AChE,
BuChE catalytic monomers assemble into both globular
and asymmetric multimers, and the asymmetric multimers
bear a collagenase-sensitive subunit (Vigny et al., 1978;
Toutant et al., 1985). To determine whether ColQ serves
as the collagen tail for BuChE, we assayed sucrose density
gradients in the presence of a selective inhibitor of AChE,
BW284c51. Asymmetric and globular forms of BuChE
were detectable in control muscle (Fig. 4, d and e). As re-
ported previously, S values of BuChE differed from those
of AChE (Vigny et al., 1978; Krejci et al., 1997), provid-
ing assurance that the activity seen in the presence of
BW284c51 did not reflect incomplete inhibition of AChE.
Moreover, activity was inhibited by the selective inhibitor
of BuChE, iso-OMPA (data not shown). Globular iso-
forms of BuChE were retained in ColQ2/2 mutants, but no
asymmetric BuChE was detectable (Fig. 4, d and e). Thus,
the ColQ gene appears to encode the collagenous tails of
both AChE and BuChE.
Lacking antibodies to BuChE, we used the histochemi-
cal stain of Karnovsky and Roots (1964) to localize BuChE
in control and mutant muscles. This method relies on hy-
drolysis of the acetylcholine analogue, acetylthiocholine,
which is cleaved by both AChE and BuChE. At P20, reac-
tion product was readily detectable at ColQ2/2 synaptic
sites, although levels were substantially reduced compared
with controls (Fig. 5, a and b). The AChE inhibitor
BW284c51 had no effect on the staining of ColQ2/2 synap-
tic sites, but decreased staining in controls to approxi-
mately the level seen in mutants (Fig. 5, c and d). This re-
sult provides independent evidence that AChE is depleted
from  ColQ2/2 neuromuscular junctions. In contrast, the
BuChE inhibitor iso-OMPA decreased staining of control
synaptic sites only slightly, but completely abolished stain-
ing of ColQ2/2 synaptic sites (Fig. 5, e and f). Thus, the
synaptic acetylcholine-hydrolyzing activity in mutants is
largely or entirely BuChE. Reaction product was unde-
tectable in controls even after prolonged incubation when
a mixture of BW284c51 plus iso-OMPA was added with
the substrate, indicating that AChE and BuChE together
account for most or all of the ACh-hydrolyzing activity at
control synapses (Fig. 5, g and h).
To obtain information on the molecular forms and cellu-
lar localization of synaptic BuChE, we treated cross-sec-
tions in various ways then stained them in the presence of
BW284c51. In both control and ColQ2/2 muscle, reaction
product was tightly associated with synaptic sites (Fig. 5, i
and j). Pretreatment of sections with either collagenase,
which releases matrix-associated enzyme, or with the de-
tergent Triton X-100, which releases membrane bound or
intracellular enzyme, reduced staining of synaptic sites in
control muscles (Fig. 5, k and m). Combined treatment
Figure 3. Mepps recorded in muscle fibers from 40-d-old ColQ1/2
(top) and ColQ2/2 (bottom) mice. Addition of the AChE inhibi-
tor fasciculin-2 (320 nM) to the bath increased the amplitude and
prolonged the decay time constant of mepps in control muscle
but had no significant effect on the size or shape of mepps in
ColQ2/2 muscle. Each trace represents the average of 50 mepps.
The decay phases of averaged mepps were fitted by a single ex-
ponential from 10% to 90% of the maximal amplitude (vertical
lines). The difference in mepp amplitudes between ColQ1/2 and
ColQ2/2 muscles is due to differences in muscle fiber diameter
and input resistance.The Journal of Cell Biology, Volume 144, 1999 1354
with collagenase and Triton X-100 removed all detectable
BuChE (Fig. 5, o and p). Thus, both matrix- and mem-
brane-associated BuChE are present at control synapses.
In ColQ2/2 muscle, collagenase treatment had no effect on
the level of BuChE (Fig. 5 l) but detergent treatment abol-
ished all staining (Fig. 5 n), confirming the absence of
matrix-associated BuChE and showing that residual activ-
ity is membrane-associated. Denervation, which causes
loss of nerve terminals and rapid remodeling of terminal
Schwann cells, led to complete loss of this membrane-asso-
ciated BuChE from ColQ2/2 synapses but had little effect
on controls (Fig. 5, q and r). Together, these results sug-
gest that both membrane- and matrix-associated forms of
BuChE are normally concentrated at the neuromuscular
junction. The BuChE of the synaptic cleft is predomi-
nantly matrix-associated, asymmetric, and requires ColQ
Figure 4. Molecular forms of cholinesterase in neonatal ColQ mutant muscles.
DS and HS pools of cholinesterase, which correspond to globular and asymmetric
forms, respectively, were separated on sucrose gradients. Fractions were incu-
bated in the presence of the BuChE inhibitor iso-OMPA (a and b) or the AChE
inhibitor BW284c51 (d and e), to selectively assay AChE or BuChE, respectively.
a–e show profiles from representative gradients. In each case, ColQ2/2, ColQ1/2,
and ColQ1/1 littermates were assayed in parallel, and with identical incubation
times. High background levels in e reflect low specific activity, which necessitated
overnight incubation of samples. c shows average AChE activities from all exper-
iments, expressed as total activity in International Units (IU) per muscle. In the
absence of ColQ, muscles are devoid of asymmetric forms of AChE and BuChE.
Levels of G4
na AChE are also dramatically reduced. At P20, asymmetric AChE
and BuChE were also completely absent in ColQ2/2, but G4 AChE was present.Feng et al. Collagen Q Mutant Lacks Synaptic Acetylcholinesterase 1355
for assembly or localization. Membrane-associated BuChE
that persists in the absence of ColQ, in contrast, is likely to
be associated with nerve terminals or terminal Schwann
cells, although we cannot exclude the possibility that it is
postsynaptic.
Although the synapse-associated BuChE in ColQ2/2
muscles did not appear to be localized to the synaptic cleft,
it might have been near enough to hydrolyze released
acetylcholine. We tested this possibility by determining
whether iso-OMPA affected the decay of mepps recorded
from ColQ2/2 neuromuscular junctions. No significant ef-
fect was seen (t 5 2.70 6 0.15 ms in normal saline and
2.98 6 0.49 ms in the presence of 10 mM iso-OMPA; n 5
4; P . 0.2). Therefore, although there is synapse-associ-
ated BuChE in ColQ2/2 mice, it does not appear to pro-
vide a mechanism to compensate for loss of AChE.
Synaptic Structure Is Abnormal in ColQ Mutants
To assess the size and shape of neuromuscular junctions in
ColQ2/2 muscle, thick longitudinal sections were stained
with rhodamine-a-bungarotoxin. In controls, the AChR-
rich membrane is a roughly circular plaque at birth, then
passes through a perforated-plaque stage (Steinbach, 1981)
and eventually matures into a pretzel-like array of distinct
AChR-rich branches by P20 (Fig. 6 a). The precise geome-
try of branches is unique at each synaptic site, but the gen-
eral pattern is stereotyped. In mutant homozygotes, in
contrast, synaptic geometry was variable. Some synaptic
sites were smaller than controls but roughly normal in ap-
pearance (Fig. 6 b), some retained the immature appear-
ance characteristic of z1-wk-old controls (Fig. 6 c), and
some appeared fragmented (Fig. 6 d). Approximately 40%
of the neuromuscular junctions were normal in geometry,
another 40% were fragmented, and the remaining 20%
were immature.
Electron microscopy revealed two structural abnormali-
ties at synaptic sites in ColQ2/2 muscles. First, the cyto-
plasm beneath the postsynaptic membrane was often rid-
dled with holes, consistent with a localized degenerative
response (Fig. 7 b). Such local degeneration has been ob-
served after acute inhibition of AChE (Laskowski et al.,
1977), and is believed to result from entry of Ca21 through
excessively activated AChRs (Leonard and Salpeter, 1979).
Consistent with this interpretation, signs of necrosis were
seldom observed in nonsynaptic regions of ColQ2/2 mus-
cle, and no signs of muscle fiber degeneration and regener-
ation (such as central nuclei, which are diagnostic of im-
mature or regenerated fibers) were detectable. Second,
nerve terminals were sometimes partially enwrapped by
processes of Schwann cells (Fig. 7 d). Such enwrapment
has been seen in several pathological situations, and can
occur after muscle damage, or as a direct consequence of
abnormalities in the synaptic cleft (Duchen et al., 1974; Jir-
manová, 1975; Noakes et al., 1995; Patton et al., 1998). Be-
cause Schwann cell processes are impermeable to neu-
rotransmitter, their intrusion into the synaptic cleft might
represent one adaptive mechanism by which ColQ2/2 syn-
apses limit activation of AChRs.
Interestingly, the incidence of subsynaptic necrosis and
Schwann cell enwrapment of nerve terminals varied as a
function of age. At P20, nearly two-thirds of synaptic sites
Figure 5. Sections of muscle from P20 ColQ2/2 and ColQ1/2 lit-
termates stained for cholinesterase activity by the Karnovsky
method. a–h are longitudinal sections; i–r are cross-sections. (a
and b) Levels of cholinesterase activity are much higher at con-
trol than ColQ2/2 endplates. (c, d, i, and j) BW284c51 (BW), a se-
lective inhibitor of AChE, has no effect on synaptic cholines-
terase activity in ColQ2/2 muscle, but decreases activity in
controls to a level equivalent to that in the mutant. (e and f) Iso-
OMPA, a selective inhibitor of BuChE, has only a slight effect on
cholinesterase activity in controls but abolishes all activity in mu-
tants. (g and h) No activity is detectable in either muscle in the
presence of both BW284c51 and iso-OMPA. These results indi-
cate that both AChE and BuChE are present at control end-
plates, but only BuChE at ColQ2/2 endplates. (k and l) Incuba-
tion of sections with collagenase to release asymmetric enzyme
before staining for BuChE (BW1) reduces activity in controls
but has no effect at ColQ2/2 synapses. (m and n) After incuba-
tion with Triton X-100 to release membrane-bound enzyme,
some BuChE activity persists at control synapses but is abolished
at ColQ2/2 synapses. (o and p) No BuChE activity is detectable
in controls or mutants after sequential treatment with Triton and
collagenase. (q and r) 3 d after nerve section, when nerve termi-
nals have degenerated, BuChE persists at control synaptic sites
but is lost from mutant synaptic sites. Bar, 20 mm.The Journal of Cell Biology, Volume 144, 1999 1356
encountered (80/125) showed clear signs of necrosis. By 6 mo
of age, however, ,5% of synaptic profiles (2/71) showed
necrosis, and many were indistinguishable from controls
(compare Fig. 7, a and c). This difference raises the possi-
bility that damage occurring early is repaired and that
compensatory mechanisms, such as Schwann cell enwrap-
ment, prevent damage from recurring. Indeed, the in-
cidence of nerve terminals partially or completely en-
wrapped by Schwann cell processes increased somewhat,
from one-third (42/125) at P20 to over one-half (39/71) at
6 mo of age. This difference suggests either that Schwann
cell enwrapment is progressive, or that individuals with
more complete enwrapment are more likely to survive.
Necrosis and Schwann cell wrapping were seen in only 1
and 4 of 83 control endplates, respectively.
Finally, we stained sections of muscle from ColQ2/2
mice and littermate controls with a panel of antibodies
to proteins present at synaptic sites. These included the
transmembrane proteins a-sarcoglycan and b-dystrogly-
can, which are present throughout the muscle fiber but
concentrated in the postsynaptic membrane; rapsyn and
utrophin, which are selectively associated with the subsyn-
aptic cytoplasm; and agrin, which is concentrated in synap-
tic basal lamina (Sanes and Lichtman, 1999). The distribu-
Figure 6. Geometry of synapses in ColQ2/2 mice.
Longitudinal sections of P20 control (a) and ColQ2/2
muscle were stained with rhodamine-a-bungaro-
toxin. In controls, the postsynaptic membrane con-
tains a set of interconnected AChR-rich gutters. In
mutants, some synaptic sites are relatively normal in
appearance (b), other appears immature (c), and
still others appear fragmented (d). Bar, 10 mm.
Figure 7. Ultrastructure of
synapses in ColQ2/2 mice.
Electron micrographs from
P20 control (a), P20 ColQ2/2
(b), and P180 ColQ2/2 (c and
d) muscles. In controls, nerve
terminals lie atop a folded
postsynaptic membrane and
are capped by processes of
Schwann cells. In ColQ2/2
mutants, the subsynaptic cy-
toplasm appears necrotic at
some synapses (b), and some
nerve terminals are en-
wrapped by Schwann cells
(d). Even at 6 mo of age,
however, some mutant syn-
apses appear normal (c). Bar,
1 mm.Feng et al. Collagen Q Mutant Lacks Synaptic Acetylcholinesterase 1357
tion of all of these markers was qualitatively similar in
control and homozygous mutant mice (Fig. 8, a–j).
We also stained sections with the lectin VVA-B4. VVA-
B4 binds to glycoconjugates that terminate with a b-N-ace-
tylgalactosaminyl residue and selectively stains the synap-
tic cleft at the neuromuscular junction (Scott et al., 1988).
We showed previously that VVA-B4 binds to asymmetric
but not globular forms of AChE in muscle, but presented
indirect evidence that other VVA-B4–binding proteins
were also present in the synaptic cleft (Scott et al., 1988;
Martin and Sanes, 1995). VVA-B4 stained synaptic sites
nearly as intensely in ColQ2/2 muscle as in control muscle
(Fig. 8, k and l), providing direct evidence for the existence
of additional synaptic VVA-B4–binding moieties.
ColQ Is Required for Assembly of All
Asymmetric AChE
Asymmetric forms of AChE are most abundant in skeletal
muscle, but are also present in several other tissues (Tou-
tant and Massoulié, 1988). To determine whether asym-
metric AChE in nonmuscle tissues requires ColQ for as-
sembly, we analyzed HS extracts of brain and heart. Low
levels of asymmetric AChE were detectable in both tissues
from control mice but in neither tissue from ColQ2/2 mice
(Fig. 9).
We also made a preliminary survey of tissue structure in
the major organs of ColQ2/2 mice, but found no abnor-
malities.
Discussion
Previous biochemical studies have shown that the ColQ
protein is a collagenous subunit of asymmetric AChE, and
suggested that it is critical for accumulation of AChE in
the synaptic cleft of the neuromuscular junction. Analysis
of ColQ2/2 mutant mice has now allowed us to ascertain,
in situ, the roles that ColQ plays in the assembly and an-
choring of AChE and in the development and function of
Figure 8. Molecular architecture of synapses in ColQ2/2 mice. Sections from ColQ2/2 and control muscle were doubly stained with
rhodamine-a-bunagrotoxin (a9–l9) plus antibodies to a-sarcoglycan (a and b), b-dystroglycan (c and d), rapsyn (e and f), utrophin (g and
h), or agrin (i and j), or with the lectin VVA-B4 (k and l). No qualitative differences were apparent between mutant and control syn-
apses. Bar, 10 mm.The Journal of Cell Biology, Volume 144, 1999 1358
the neuromuscular junction. Specifically, we have been
able to answer the seven questions posed in the Introduc-
tion.
First, no asymmetric AChE is present in muscles that
lack ColQ, presumably because the ColQ protein forms
the collagen tail that endows asymmetric forms with their
distinguishing feature. This result was expected but not in-
evitable. For example, ColQ might have been only one of
multiple collagenous subunits, a possibility suggested by
immunological studies showing a structural change in the
collagen tail during posthatching development in birds
(Tsim et al., 1988b). Alternatively, a synaptic collagen that
normally plays other roles (Miner and Sanes, 1994, 1996)
might have been capable of compensating for lack of ColQ
in mutants.
Second, muscles from newborn ColQ2/2 mice lack not
only all asymmetric AChE, but also the nonamphiphilic
tetrameric form of AChE, G4
na. This observation was un-
expected because the G4
na molecules have been assumed
to be homotetramers of AChET catalytic subunits. Possi-
ble explanations for this result include the following. G4
na
molecules may be derived from collagen-tailed molecules
by proteolysis of the collagen tail, either in vivo or after
extraction. Assembly of the tetramer might require tran-
sient association of AChET with ColQ. Assembly might
require an alternatively spliced product of the ColQ gene
that contains the amino-terminal PRAD domain, but not
the collagenous domain. Such alternatively spliced prod-
ucts do in fact occur (Krejci et al., 1997), but have not yet
been characterized. Some of the G4
na may comprise tet-
ramers associated with a single full-length collagen chain
rather than a triple helix; such molecules sediment around
10S (Krejci, E., unpublished results). In any event, muscles
of ColQ2/2 mice did contain both amphiphilic and nonam-
phiphilic tetramers (G4
a and G4
na) at P20. These tetramers
might have been assembled without any organizer or
might contain an alternate organizing subunit such as the
still incompletely characterized P subunit (Massoulié et al.,
1993). Thus, although the PRAD of ColQ can induce tet-
ramerization of AChET (Bon et al., 1997; Simon et al.,
1998), and may do so in vivo at P0, there are clearly addi-
tional PRAD-independent mechanisms for forming tet-
ramers.
Third, no detectable AChE is present at synaptic sites in
ColQ2/2 muscles. Histochemical, immunochemical, toxi-
cological, and electrophysiological assays all gave similar
results in this regard. The lack of synaptic AChE could re-
flect loss of collagen-tailed AChE and/or loss of G4 forms.
We favor the interpretation that all synaptic AChE is col-
lagen-tailed because all of the histochemically detectable
AChE can be removed by collagenase treatment of sec-
tions (data not shown) or tissue (Hall and Kelly, 1971). In
addition, all globular forms (G1
a, G2
a, G4
a, and G4
na) are
present in ColQ2/2 mice at P20, yet synaptic AChE is ab-
sent at all ages tested. Globular AChE is associated with
isolated basal lamina from frog muscles (Anglister et al.,
1994), but this may result from the alterations produced in
the experimental system of muscle and nerve degenera-
tion.
Fourth, ColQ is required for assembly or accumulation
of asymmetric BuChE as well as AChE. In birds, collagen-
tailed molecules containing both AChE and BChE sub-
units have been detected in muscles of hatchlings (Tsim
et al., 1988a), suggesting that both enzymes use a common
tail. Likewise, Krejci et al. (1997) showed that antibodies
to ColQ interact with both AChE and BuChE as assessed
by sucrose density centrifugations. Taken together with
these biochemical data, our genetic results strongly sup-
port the conclusion that the ColQ gene produces the col-
lagen tails for both AChE and BuChE.
Fifth, the function of the neuromuscular junction is im-
paired in the absence of ColQ. However, the defects are
not as severe as might be expected, considering the dra-
matic effects of acutely administering extremely selective
blockers of peripheral AChE such as fasciculin. In particu-
lar, movements of ColQ2/2 mice are relatively normal,
while fasciculin-treated normal mice are paralyzed. More-
over, the postsynaptic necrosis observed in ColQ2/2 wean-
lings, a likely result of excessive calcium influx through
AChRs (Leonard and Salpeter, 1979), is largely absent
from those mutants that survive to later ages. These obser-
vations suggest that neuromuscular junctions compensate
for the absence of AChE. Compensation does not appear
to involve persistence or upregulation of BuChE: asym-
metric BuChE is lost in the mutant and the BuChE inhibi-
tor, iso-OMPA, does not affect the time course of mepps.
Figure 9. ColQ is required
for assembly of asymmetric
forms of AChE in heart and
brain. HS extracts of heart
(a) or brain (b) of 2-mo-old
mice were fractionated on
sucrose gradients and as-
sayed for AChE. Only por-
tions of the gradient corre-
sponding to 8–20S material
are shown. No asymmetric
AChE was detected in
ColQ2/2 tissue.Feng et al. Collagen Q Mutant Lacks Synaptic Acetylcholinesterase 1359
Instead, ultrastructural studies suggest a simple structural
mechanism to limit the amount of neurotransmitter that
reaches the postsynaptic membrane: invasion of the synap-
tic cleft by Schwann cell processes at ColQ2/2 synapses.
Enwrapment of nerve terminals by Schwann cell processes
is, in fact, actively regulated by another component of syn-
aptic basal lamina, laminin-11 (Patton et al., 1998). ColQ
might exert a similar effect. In addition, compensatory
changes in quantal size and quantal content may occur;
such homeostatic changes have been documented in re-
sponse to several chemical or genetic perturbations of the
efficacy of neuromuscular transmission in both vertebrates
and invertebrates (reviewed in Landmesser, 1998). Cur-
rently, we are using electrophysiological methods to seek
such alterations in ColQ2/2 mice, with the aim of learning
how the synapse combines structural and physiological
compensations to adapt to the challenge posed by AChE
deficiency.
Sixth, initial formation of the neuromuscular junction
proceeds in the absence of ColQ and AChE. AChE pro-
motes the extension of neurites from cultured motoneu-
rons by a noncatalytic mechanism (Sternfeld et al., 1998;
see also Small et al., 1995), and overexpression of AChE
in transgenic frogs and mice perturbs formation of neuro-
muscular junctions in vivo (Seidman et al., 1994; Andres
et al., 1997; Sternfeld et al., 1998). Our results imply that
the developmental roles of ColQ and AChE at the syn-
apse are either subtle or masked by compensatory mecha-
nisms. However, it remains possible that expression of
AChE at other sites is crucial for synaptogenesis. More-
over, at later stages, there are clear defects in the matura-
tion of ColQ2/2 neuromuscular junctions: some remain
immature in geometry and others appear fragmented.
These abnormalities could reflect a direct requirement for
AChE or ColQ in synaptic maturation or maintenance,
but might also be secondary consequences of subsynaptic
necrosis or alterations in activity levels. Further experi-
ments will be required to distinguish these alternatives.
Seventh, ColQ is required for assembly or accumulation
of asymmetric AChE in all tissues tested, but tissues other
than skeletal muscle are not obviously defective in struc-
ture or function. However, it is premature to conclude that
ColQ plays no roles in these tissues. For example, asym-
metric AChE is concentrated in synaptic layers of the ret-
ina (Reiss et al., 1996); analyses of these synapses have not
yet been undertaken. In addition, it is tempting to specu-
late that in AChE-poor tissues, ColQ or other PRAD-con-
taining products of the ColQ gene serve to anchor proteins
other than AChE to membranes or matrix. Identification
of such proteins will guide the search for subtle pheno-
types in ColQ2/2 mice.
Finally, it is interesting to note the parallels between
ColQ2/2 mice and humans with AChE-deficiency syn-
drome (CMS-Ic). This syndrome was described by Engel
et al. (1977) over 20 years ago, and was reported just this
year to result from defects in the human COLQ gene
(Donger et al., 1998; Ohno et al., 1998). Some patients ap-
pear to be protein nulls, while others have mutations in the
carboxy terminus of ColQ that permit formation of asym-
metric AChE but prevent its stable association with the
basal lamina of the synaptic cleft. All of the COLQ pa-
tients are severely myasthenic, as are the ColQ2/2 mice,
making the mice a valid model for assessing pathogenic
mechanisms and therapeutic interventions.
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